[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357209-105":59,"doc-detail-357209-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","maackia-amurensis-seed-lectin-inhibits-oral-squamous-cell-carcinoma-tumorigenesis-suppressing-n6-methyladenosine-modificationmediated-sry-box-transcription-factor-2-expression","Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis - suppressing N6-methyladenosine modification–mediated SRY-box transcription factor 2 expression","","Combining Maackia amurensis seed lectin (MASL) with first-line chemotherapeutics is reported to improve outcomes in oral squamous cell carcinoma (OSCC), but the mechanism is unclear. This study used GEO dataset mining, RT-qPCR, western blotting, and methylated RNA immunoprecipitation to assess SRY-box transcription factor 2 (SOX2) and N6-methyladenosine pathways. MASL reduced N6-methyladenosine levels and SOX2 expression, while SOX2 overexpression reversed MASL’s inhibition of OSCC proliferation and colony formation. MASL may enhance chemotherapy sensitivity by suppressing the N6-methyladenosine/SOX2 axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/maackia-amurensis-seed-lectin-inhibits-oral-squamous-cell-carcinoma-tumorigenesis-suppressing-n6-methyladenosine-modificationmediated-sry-box-transcription-factor-2-expression/357209/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/maackia-amurensis-seed-lectin-inhibits-oral-squamous-cell-carcinoma-tumorigenesis-suppressing-n6-methyladenosine-modificationmediated-sry-box-transcription-factor-2-expression/357209.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on MASL in OSCC?","Question",{"text":112,"@type":113},"To determine the underlying mechanism by which Maackia amurensis seed lectin contributes to the treatment of oral squamous cell carcinoma, focusing on the N6-methyladenosine modification pathway and SOX2 expression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which methods were used to measure SOX2 and N6-methyladenosine in OSCC?",{"text":117,"@type":113},"The study used GEO dataset mining, RT-qPCR, western blot analysis, and methylated RNA immunoprecipitation to detect N6-methyladenosine methylation levels of SOX2.",{"name":119,"@type":110,"acceptedAnswer":120},"How did MASL affect OSCC cell behavior and what role did SOX2 play?",{"text":121,"@type":113},"MASL reduced N6-methyladenosine modification levels and decreased SOX2 expression; it also inhibited OSCC cell proliferation and colony formation. SOX2 overexpression reversed these inhibitory effects of MASL.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357209,1790208956,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Maackia amurensis seed lectin inhibits oralsquamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification–mediated SRY-box transcription factor 2 expression  \nYong Du 1, Haiyan Yang2 , Hongguang Lian2, Dan Li2, Weina Liu2, Linyuan Zhao2 and Yufeng Zhang3  \nJournal of International Medical Research 2026, Vol. 54(6) 1–14! The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605261457780](DOI: 10.1177/03000605261457780)[ ](DOI: 10.1177/03000605261457780)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nObjective: Studies have indicated that combining Maackia amurensis seed lectin with first-line chemotherapeutic agents enhances the efficacy of treatment for oral squamous cell carcinoma. The study aimed to investigate the underlying mechanism of Maackia amurensis seed lectin in the treatment of oral squamous cell carcinoma.  \nMethods: Gene Expression Omnibus dataset mining, reverse transcription–quantitative polymerase chain reaction, and western blot analysis were performed to identify the expression of SRY-box transcription factor 2, methyltransferase 3, and YTH domain-containing protein 1 in oralsquamous cell carcinoma. The N6-methyladenosine methylation levels of SRY-box transcription factor 2 were detected though methylated RNA immunoprecipitation. The effects of Maackia amurensis seed lectin and SRY-box transcription factor 2 on oral squamous cell carcinoma cells were determined via Cell Counting Kit-8 and colony formation assays.  \nResults: The results demonstrated that increased expression of SRY-box transcription factor 2 in oral squamous cell carcinoma is correlated with elevated levels of N6-methyladenosine  \n1 Department of Stomatology, The Second Hospital of Hebei Medical University, China  \n2Department of Pathology, The Second Hospital of Hebei Medical University, China  \n3Department of Radiotherapy, The Second Hospital of Hebei Medical University, China  \nCorresponding author:  \nYufeng Zhang, the Second Hospital of Hebei Medical University, Shijiazhuang, China.  \nEmail: [zhangyufeng2727@163.com](zhangyufeng2727@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nmodification, and treatment with Maackia amurensis seed lectin reduces the N6-methyladenosine modification level and SRY-box transcription factor 2 expression. Moreover, overexpression of SRY-box transcription factor 2 reversed the inhibitory effects of Maackia amurensis seed lectin on oral squamous cell carcinoma cell proliferation and colony formation.  \nConclusions: Maackia amurensis seed lectin may inhibit oral squamous cell carcinoma cell proliferation by suppressing N6-methyladenosine modification–mediated SRY-box transcription factor 2 expression, thereby improving chemotherapy sensitivity in oral squamous cell carcinoma.  \nKeywords  \nOral squamous cell carcinoma, Maackia amurensis seed lectin, SRY-box transcription factor 2, N6-methyladenosine modification, methyltransferase-like 3, YTH domain-containing protein 1  \nDate received: 27 December 2025; accepted: 20 May 2026  \nIntroduction  \nOral squamous cell carcinoma (OSCC) is the most prevalent form of squamous cell carcinoma of the head and neck region, accounting for approximately 90% of all oral cancers. This malignancy is characterized by its high rate of recurrence, invasion, and metastasis, which poses a significant threat to p","cbCaib0CjZz87GgE","https://ap.wps.com/l/cbCaib0CjZz87GgE","pdf",682289,14,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main objective of the study on MASL in OSCC?\",\"answer\":\"To determine the underlying mechanism by which Maackia amurensis seed lectin contributes to the treatment of oral squamous cell carcinoma, focusing on the N6-methyladenosine modification pathway and SOX2 expression.\"},{\"question\":\"Which methods were used to measure SOX2 and N6-methyladenosine in OSCC?\",\"answer\":\"The study used GEO dataset mining, RT-qPCR, western blot analysis, and methylated RNA immunoprecipitation to detect N6-methyladenosine methylation levels of SOX2.\"},{\"question\":\"How did MASL affect OSCC cell behavior and what role did SOX2 play?\",\"answer\":\"MASL reduced N6-methyladenosine modification levels and decreased SOX2 expression; it also inhibited OSCC cell proliferation and colony formation. SOX2 overexpression reversed these inhibitory effects of MASL.\"}]","Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis - suppressing N6-methyladenosine modification–mediated SRY-box transcription factor 2 expression | PDF",1790129348,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f621f12a1a0331a1e2f7e1cc23c0634.webp",983,1399,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dfaffd7e7158fe8b764f5a671effa80.webp",982,1398,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a828ccea18b43a4781eff159130e64eb.webp",981,1396,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83600e18d5341662d3e71224ca8f8178.webp",980,1395]